Business
HLS Therapeutics to Host 2018 Third Quarter Results Conference Call
HLS Therapeutics to Host 2018 Third Quarter Results Conference Call Canada NewsWir...
About this update from Hls Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\nHLS Therapeutics to Host 2018 Third Quarter Results Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Nov. 1, 2018\n\n\n\nTORONTO, Nov. 1, 2018 /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX-V: HLS), a specialty pharmaceutical company specializing in CNS and Cardiovascular markets, announces that it will release its third quarter 2018 financial results by press release at 6:30 am Eastern Time on Thursday, November 15, 2018. The Company will hold a conference call that same day at 8:30 am Eastern Time to discuss its results. The call will be hosted by Mr. Greg Gubitz, Chief Executive Officer, Mr. Gilbert Godin, President and Chief Operating Officer and Mr. Tim Hendrickson, Chief Financial Officer. \nConference Call Details\nDATE: \nThursday, November 15, 2018\nTIME:  \n8:30 am ET\nDIAL-IN NUMBER:  \n(888) 231-8191 or (647) 427-7450 \nWEBCAST LINK:   \nhttps://event.on24.com/wcc/r/1858367/B0980D666D5E199E6680A23D34BA7DAF \nTAPED REPLAY: \n(855) 859-2056 or (416) 849-0833 \nREPLAY PASSCODE: \n7958419\n \nA link to the live audio webcast of the conference call will also be available on the events page of the investors section of HLS Therapeutics' website at www.hlstherapeutics.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to hear the webcast. The taped replay will be available for 14 days and the archived webcast will be available for 90 days.\nABOUT HLS THERAPEUTICS INC.\nFormed in 2015, HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established branded pha...